Haleon (LSE:HLN) Receivables Turnover : 2.16 (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Haleon Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Haleon's Revenue for the three months ended in Mar. 2024 was £2,919 Mil. Haleon's average Accounts Receivable for the three months ended in Mar. 2024 was £1,352 Mil. Hence, Haleon's Receivables Turnover for the three months ended in Mar. 2024 was 2.16.

Haleon Receivables Turnover Historical Data

The historical data trend for Haleon's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Haleon Receivables Turnover Chart

Haleon Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Receivables Turnover

6.07

7.21

7.16

7.74

7.96

Haleon Quarterly Data
	Dec19	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Receivables Turnover	Get a 7-Day Free Trial									2.01	1.35	1.37	2.05	2.16

Competitive Comparison of Haleon's Receivables Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, Haleon's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Haleon's Receivables Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Haleon's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Haleon's Receivables Turnover falls into.

Haleon Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Haleon's Receivables Turnover for the fiscal year that ended in Dec. 2023 is calculated as

	Receivables Turnover (A: Dec. 2023 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Dec. 2023 )	/ (	(Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )
=	11302	/ (	(1487	+	1352)	/	2 )
=	11302	/	1419.5
=	7.96

Haleon's Receivables Turnover for the quarter that ended in Mar. 2024 is calculated as

	Receivables Turnover (Q: Mar. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Mar. 2024 )	/ (	(Accounts Receivable (Q: Dec. 2023 )	+	Accounts Receivable (Q: Mar. 2024 ))	/	count )
=	2919	/ (	(1352	+	0)	/	1 )
=	2919	/	1352
=	2.16

Haleon (LSE:HLN) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Haleon Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Haleon's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Haleon (LSE:HLN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Haleon PLC (LSE:HLN) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

HLNCF:USA HLN:USA HLN1:Mexico HLNl:UK H6D0:Germany

Address

The Heights, Building 5, First Floor, Surrey, Weybridge, GBR, KT13 0NY

Website

https://www.haleon.com

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.